Request that the Commissioner of Food and Drugs amend the sulfite warning requirement in 21 C.F.R. 201.22 for sulfite-containing epinephrine for injection for use in emergency situations, in order to remove misleading information and acknowledge the current availability of approved epinephrine products that do not contain sulfite.
🏛 Food and Drug Administration (FDA)FDA-2017-P-3352
Documents
0
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
No documents mirrored for this docket yet.